Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
This program evaluates the efficiency and necessity of the treatments you're seeking
Main Research Findings 1) The findings of the study suggest that Dihexa may have the potential to treat disorders, such as Alzheimers disease, that may benefit from the augmentation of synaptic connectivity
The defined molecular structures and sequence integrity of each component make this blend suitable for laboratory workflows requiring reproducibility, traceability, and controlled experimental conditions
Regulatory history: Sermorelin was FDA-approved in 1997 under the brand name Geref for the treatment of growth hormone deficiency in children
US$ 28.81
US$ 25.72
US$ 22.22
